scispace - formally typeset
Z

Zhaohai Zheng

Researcher at Zhejiang University

Publications -  6
Citations -  1923

Zhaohai Zheng is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications receiving 1200 citations.

Papers
More filters
Journal ArticleDOI

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.

TL;DR: Clinical manifestations such as fever, shortness of breath or dyspnea were associated with the progression of disease, and laboratory examination such as aspartate amino transferase(AST) > 40U/L, creatinine(Cr) ≥ 133mol/l, hypersensitive cardiac troponin I(hs-cTnI) > 28pg/mL, procalcitonin(PCT) > 0.5mg/L predicted the deterioration of disease.
Journal ArticleDOI

Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy.

TL;DR: Chest CT has a high sensitivity for detecting COVID-19, especially in a region with severe epidemic, which is helpful to early recognize suspicious cases and might contribute to confine epidemic and in the context of emergency disease control.
Journal ArticleDOI

Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction

TL;DR: Investigation of the effect of Shenmai injection on coronary microvascular dysfunction found that pretreatment with SMI could improve CMD by alleviating oxidative stress, inflammatory response, and apoptosis and then improving vascular endothelial function and microv vascular structure.
Journal ArticleDOI

Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy

TL;DR: In this paper, the effect of Musk Tongxin Dropping Pill (MTDP) on myocardial remodeling and microcirculation dysfunction in diabetic cardiomyopathy (DCM) was explored.
Journal ArticleDOI

Impact of the COVID-19 Pandemic on ST-Elevation Myocardial Infarction Management in Hunan Province, China: A Multi-Center Observational Study

TL;DR: During the COVID-19 pandemic outbreak in China, there was a decline in the number of STEMI admissions and STEMI-related PCI procedures, however, the key quality indicators ofSTEMI care were not significantly affected and restructuring health services has not significantly adversely influenced the in-hospital outcomes.